Catalyst
Slingshot members are tracking this event:
Heron (HRTX) Announces SUSTOL ER Injection Now Included in National Comprehensive Cancer Network's Clinical Practice Guidelines in Oncology for Antiemesis Version 1.2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| HRTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 24, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hrtx, Injection, Sustol, Extended Release, National Comprehensive Cancer Network, Clinical Practice Guidelines, Oncology, Antiemesis
